Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,726 | 30,699 | 8,859 | 10,511 | 7,977 |
| Marketable Securities | 123,479 | 60,065 | 92,621 | 33,251 | 16,492 |
| Receivables | 15,722 | 4,494 | 1,592 | 2,942 | 261 |
| Income taxes - deferred | 1,447 | 11,123 | N/A | N/A | N/A |
| TOTAL | $170,641 | $107,975 | $104,713 | $47,308 | $25,099 |
| Non-Current Assets | |||||
| PPE Net | 5,886 | 1,803 | 1,121 | 611 | 534 |
| Investments And Advances | 64,238 | 41,003 | 10,703 | 1,656 | 0 |
| Other Non-Current Assets | 5,248 | 4,634 | 436 | 2,587 | 463 |
| TOTAL | $75,372 | $47,440 | $12,260 | $4,854 | $997 |
| Total Assets | $246,013 | $155,415 | $116,973 | $52,162 | $26,096 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,543 | 1,874 | 1,481 | 1,851 | 566 |
| Accrued Expenses | 3,962 | 2,872 | 3,035 | 3,866 | 1,583 |
| TOTAL | $6,704 | $4,746 | $4,526 | $5,734 | $2,149 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 10 | 17 | N/A |
| Other Non-Current Liabilities | 3,152 | 2,015 | 1,979 | 2,499 | 1,993 |
| TOTAL | $3,152 | $2,015 | $1,979 | $2,499 | $1,993 |
| Total Liabilities | $9,856 | $6,761 | $6,505 | $8,233 | $4,142 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,795 | 18,604 | 17,962 | N/A | N/A |
| Common Shares | 187 | 188 | 181 | 13 | 12 |
| Retained earnings | 5,980 | -73,012 | -107,450 | -115,374 | -131,970 |
| Other shareholders' equity | 33 | -102 | -4 | 159,290 | 153,912 |
| TOTAL | $236,157 | $148,654 | $110,468 | $43,929 | $21,954 |
| Total Liabilities And Equity | $246,013 | $155,415 | $116,973 | $52,162 | $26,096 |